BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 20131425)

  • 1. [Chagas disease and immunodeficiency: HIV infection and transplantation].
    Le Loup G; Ibrahim K; Malvy D
    Bull Soc Pathol Exot; 2009 Dec; 102(5):310-8. PubMed ID: 20131425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chagas disease in the immunosuppressed host.
    Bern C
    Curr Opin Infect Dis; 2012 Aug; 25(4):450-7. PubMed ID: 22614520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of Chagas disease chemotherapy.
    Guedes PM; Silva GK; Gutierrez FR; Silva JS
    Expert Rev Anti Infect Ther; 2011 May; 9(5):609-20. PubMed ID: 21609270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of Chagas' disease: cutaneous manifestations in two immunosuppressed patients.
    Riganti J; Maqueda MG; Piñero MC; Volonteri VI; Galimberti RL
    Int J Dermatol; 2012 Jul; 51(7):829-34. PubMed ID: 22715827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association.
    Diazgranados CA; Saavedra-Trujillo CH; Mantilla M; Valderrama SL; Alquichire C; Franco-Paredes C
    Lancet Infect Dis; 2009 May; 9(5):324-30. PubMed ID: 19393962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Three-year survival of a patient with HIV and chagasic meningoencephalitis: case report].
    López M O
    Rev Chilena Infectol; 2010 Apr; 27(2):160-4. PubMed ID: 20556321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chagas disease. American trypanosomiasis.
    Kirchhoff LV
    Infect Dis Clin North Am; 1993 Sep; 7(3):487-502. PubMed ID: 8254156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allopurinol in the treatment of chronic Chagas' disease].
    Meirovich CI; Montrull HL; Gallerano RH; Sosa RR
    Arq Bras Cardiol; 1985 Sep; 45(3):217-23. PubMed ID: 3939099
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Trypanosoma cruzi infection in the indeterminate phase: experience and current guidelines in Argentina].
    Sosa Estani S; Segura EL
    Medicina (B Aires); 1999; 59 Suppl 2():166-70. PubMed ID: 10668259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

  • 11. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.
    Pérez-Molina JA; Sojo-Dorado J; Norman F; Monge-Maillo B; Díaz-Menéndez M; Albajar-Viñas P; López-Vélez R
    Acta Trop; 2013 Aug; 127(2):101-4. PubMed ID: 23583863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Part VI. Antiparasitic treatment for Chagas disease].
    B WA; G IH; L MI; M LJ; V PM; H IN; V AM; P JS; H MT; A IZ
    Rev Chilena Infectol; 2008 Oct; 25(5):384-9, discussion 387. PubMed ID: 18949153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recipients and donors of bone marrow transplants suffering from Chagas' disease: management and preemptive therapy of parasitemia.
    Dictar M; Sinagra A; Verón MT; Luna C; Dengra C; De Rissio A; Bayo R; Ceraso D; Segura E; Koziner B; Riarte A
    Bone Marrow Transplant; 1998 Feb; 21(4):391-3. PubMed ID: 9509974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need of a neonatal preparation for Chagas disease.
    Sosa-Estani S; Belizan JM; Althabe F; Rubinstein A
    PLoS Med; 2005 Nov; 2(11):e387. PubMed ID: 16288560
    [No Abstract]   [Full Text] [Related]  

  • 15. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
    Bocchi EA; Higuchi ML; Vieira ML; Stolf N; Bellotti G; Fiorelli A; Uip D; Jatene A; Pileggi F
    J Heart Lung Transplant; 1998 Apr; 17(4):399-405. PubMed ID: 9588585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment and follow up of Chagas Disease in immunocompromised hosts].
    Muñoz Casas Del Valle P
    Rev Chilena Infectol; 2017 Feb; 34(1):67-68. PubMed ID: 28394984
    [No Abstract]   [Full Text] [Related]  

  • 17. Recognizing and meeting the challenge of Chagas disease in the USA.
    Bowling J; Walter EA
    Expert Rev Anti Infect Ther; 2009 Dec; 7(10):1223-34. PubMed ID: 19968514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis).
    Castro JA; de Mecca MM; Bartel LC
    Hum Exp Toxicol; 2006 Aug; 25(8):471-9. PubMed ID: 16937919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
    Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
    Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation].
    Coura JR; de Abreu LL; Willcox HP; Petana W
    Rev Soc Bras Med Trop; 1997; 30(2):139-44. PubMed ID: 9148337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.